Onyx Pharma rejects buyout offer from Amgen

dimanche 30 juin 2013

Onyx Pharmaceuticals Inc on Sunday confirmed it had rejected an offer from Amgen Inc to buy the company for $120 a share in cash. The company said that the offer price "significantly undervalued" ...



via Business & Finance News - Yahoo! Finance http://finance.yahoo.com/news/onyx-pharma-rejects-buyout-offer-163328843.html

0 commentaires:

Enregistrer un commentaire